Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme

Published:2010-07 Issue:7 Volume:12 Page:738-745
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Chang Su Min¹,Granger Christopher B.²,Johansson Peter A.³,Kosolcharoen Peter⁴,McMurray John J.V.⁵,Michelson Eric L.⁶,Murray David R.⁴,Olofsson Bertil³,Pfeffer Marc A.⁷,Solomon Scott D.⁷,Swedberg Karl⁸,Yusuf Salim⁹,Dunlap Mark E.¹⁰,

Affiliation:

1. Department of Cardiology; The Methodist DeBakey Heart and Vascular Center; Houston TX USA

2. Cardiology, Duke University Medical Center; Durham NC USA

3. Astra Zeneca R&D; Mölndal Sweden

4. Section of Cardiovascular Medicine; University of Wisconsin; Madison WI USA

5. British Heart Foundation Glasgow Cardiovascular Research Centre; University of Glasgow; Glasgow Scotland UK

6. AstraZeneca LP; Wilmington DE USA

7. Cardiology, Brigham and Women's Hospital; Boston MA USA

8. Department of Emergency and Cardiovascular Medicine; University of Gothenburg; Sweden

9. Hamilton Health Sciences and McMaster University; Hamilton ON Canada

10. Heart and Vascular Center H350, MetroHealth Medical Center and Case Western Reserve University; 2500 MetroHealth Dr. Cleveland OH 44109 USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure);Hunt;J Am Coll Cardiol,2005

2. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology;Swedberg;Eur Heart J,2005

3. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II);Nguyen;Am J Cardiol,1997

4. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease;Peterson;Am J Med,2000

5. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial;Al-Khadra;J Am Coll Cardiol,1998

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction;Cochrane Database of Systematic Reviews;2021-05-22

2. Impact of renin–angiotensin system blocker after aortic valve replacement—a systematic review and meta-analysis;Annals of Palliative Medicine;2021-02

3. Correction to: Relationship Between Blood Pressure Levels on Admission and the Onset of Acute Pneumonia in Elderly Patients With Cerebral Hemorrhage;Journal of Clinical Medicine Research;2021

4. Evaluation of an Integrated Device Diagnostics Algorithm to Risk Stratify Heart Failure Patients　― Results From the SCAN-HF Study ―;Circulation Journal;2020-06-25

5. Interactions between the Cyclooxygenase Metabolic Pathway and the Renin-Angiotensin-Aldosterone Systems: Their Effect on Cardiovascular Risk, from Theory to the Clinical Practice;BioMed Research International;2018-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3